Approximately 86,478,538 units of various dietary supplements, including Ephrine Plus, Electrolyte tablets, Caffeine, and Melatonin, are being recalled because they were manufactured under conditions that did not meet Current Good Manufacturing Practice (cGMP) requirements. These deviations from standard manufacturing rules mean the safety and quality of the tablets cannot be guaranteed. The affected products were distributed in bulk to facilities in New York and Florida, where they may have been repackaged into finished consumer goods and sold through various retailers.
When products are manufactured with deviations from quality control standards, there is an increased risk that the supplements may not contain the correct ingredients, may have incorrect potencies, or could be contaminated with unknown substances during the production process.
Full refund upon return of product
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.